CytoDyn to Hold 2020 Virtual Annual Meeting of Stockholders on September 30, 2020
CytoDyn Inc. (OTC.QB: CYDY) announces its 2020 Virtual Annual Meeting of Stockholders, scheduled for September 30, 2020, at 9:30 am PT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CytoDyn Inc. (OTC.QB: CYDY) announces its 2020 Virtual Annual Meeting of Stockholders, scheduled for September 30, 2020, at 9:30 am PT. Due to health concerns from the coronavirus pandemic, in-person attendance is not allowed. Stockholders can log in to participate via the provided webcast link, and questions can be submitted online during the meeting with the passcode CYDY2020. Dr. Nader Pourhassan, CEO, will present a company overview post-business session, with materials available on the company website.
Positive
- Scheduled virtual stockholder meeting increases accessibility for investors.
- Company leadership will provide an overview, supporting transparency.
Negative
- In-person attendance restriction may limit investor engagement.
- Potential technical issues could hinder virtual meeting participation.
Details
News Market Reaction – CYDY
The recorded move for CYDY in the trading session of this news was -6.41%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
VANCOUVER, Washington, Sept. 29, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, reminds investors today the 2020 Virtual Annual Meeting of Stockholders will be held at 9:30 am PT on September 30, 2020. As stated in the Company’s proxy statement dated September 1, 2020, due to public health concerns relating to the coronavirus pandemic, stockholders will not be able to attend the Annual Meeting in person. The Company provides the following information as a reminder on how stockholders and guests can participate in the virtual meeting format:
Time: 9:30 am PT
Webcast login: http://www.meetingcenter.io/251330521
Stockholder questions: Submitted online via the meeting link, passcode CYDY2020 and their individual control number noted on their proxy card. Guests will not be able to submit questions during the meeting.
At the conclusion of the business portion of the meeting, Nader Pourhassan, Ph.D., President and Chief Executive Officer, will present an overview of the Company via a slide deck, which will be available on the Company’s website (www.cytodyn.com) at 9:30 am PT. In light of the limited amount of time for the meeting, stockholders are also encouraged to submit questions to management before 8:00 am PT tomorrow to: CYDY_team@cytodyn.com.
CYTODYN CONTACTS
Investors:
Michael Mulholland
Office: 360.980.8524, ext. 102
mmulholland@cytodyn.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.